Should antiplatelet therapy be interrupted in drug eluting stent recipients throughout the periendoscopic period? A very late stent thrombosis case re-port and review of the literature

Peng DONG; Xin-Chun YANG; Su-Yan BIAN

doi:10.11909/j.issn.1671-5411.2014.03.006

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Should antiplatelet therapy be interrupted in drug eluting stent recipients throughout the periendoscopic period? A very late stent thrombosis case re-port and review of the literature

DOI: 10.11909/j.issn.1671-5411.2014.03.006

Should antiplatelet therapy be interrupted in drug eluting stent recipients throughout the periendoscopic period? A very late stent thrombosis case re-port and review of the literature

Peng DONG

Xin-Chun YANG

Su-Yan BIAN

Keywords：Sirolimus-eluting stentThrombosisComplicationAntiplatelet therapy

Publication Date：2014-07-02

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 274-277 )

Journal of Geriatric Cardiology

ISSN：1671-5411

Year, Vol.(Issue)：2014,(3)